Betaxolol NDC 24658-700

NDC codes

FDA NDC Directory

Product NDC (as listed)24658-700Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24658-0700Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24658-700-01	24658070001	100 TABLET, FILM COATED in 1 BOTTLE (24658-700-01)Marketed from Dec 15, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betaxolol
Generic name (nonproprietary): betaxolol
Active ingredients: Betaxolol hydrochloride — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: PuraCap Laboratories LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075541
Marketing start: Aug 22, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 24658-700_7ee988e7-153d-4d55-b4ec-1a8da8f78f1dSPL ID 7ee988e7-153d-4d55-b4ec-1a8da8f78f1dSPL set ID e198244d-fda3-4015-8c01-390f3f88e238RxCUI 1297753, 1297757UNII 6X97D2XT0OUPC 0324658701011
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424658070001 followed by a unit qualifier and the quantity

Package 24658-0700-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 31, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Betaxolol is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075541

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075541
Product	Strength	Form · route	Labeler	Product NDC
Betaxolol	Betaxolol hydrochloride 20 mg/1	Tablet, Film coatedOral	PuraCap Laboratories LLC	24658-701
Betaxolol	Betaxolol hydrochloride 20 mg/1	Tablet, Film coatedOral	Epic Pharma LLC	42806-039
Betaxolol	Betaxolol hydrochloride 10 mg/1	Tablet, Film coatedOral	Epic Pharma LLC	42806-038